KEGG   DRUG: Lumacaftor - ivacaftor mixtHelp
Entry
D10685            Mixture   Drug                                   

Name
Lumacaftor - ivacaftor mixt;
Orkambi (TN)
Product
Component
Lumacaftor [DR:D10134], Ivacaftor [DR:D09916]
Remark
ATC code: 
Efficacy
Cystic fibrosis treatment
  Disease
Cystic fibrosis (CF) [DS:H00218]
Comment
Treatment of cystic fibrosis (CF)
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R07 OTHER RESPIRATORY SYSTEM PRODUCTS
   R07A OTHER RESPIRATORY SYSTEM PRODUCTS
    R07AX Other respiratory system products
     R07AX30 Ivacaftor and lumacaftor
      D10685  Lumacaftor - ivacaftor mixt
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D10685
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10685
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10685
Orphan drugs in the USA [br08355.html]
 Orphan drugs in the USA
  D10685
Pharmacogenomic biomarkers in FDA drug labels [br08341.html]
 Polymorphisms and germline mutations
  D10685
BRITE hierarchy
Other DBs
PubChem: 
ChEBI: 
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system